Health
Immune checkpoint inhibitor efficacy against glioblastoma may decrease with dexamethasone – Science Codex
Bottom Line: Among patients with glioblastoma receiving an immune checkpoint inhibitor, those who received the corticosteroid dexamethasone at baseline for cerebral edema had significantly worse overall survival.
Journal in Which the Study was Published: Clinical Cancer Research, a journal of the American Association for Cancer Research
Author: David A. Reardon, MD, clinical director of the Center for Neuro-Oncology at Dana-Farber Cancer Institute in Boston
Background: “Dexamethasone is a potent…
-
Business12 hours agoHow I’d build a $100,000 ASX portfolio from scratch
-
Noosa News7 hours agoBrisbane man Benjamin Holt speaks out about teen who allegedly organised Airbnb party that led to his house being trashed
-
Business5 hours agoSoaring one day, plunging the next. Why is the ASX 200 on a rollercoaster?
-
Noosa News20 hours agoMan thought to be ‘stable’ after Elimbah crash dies weeks later in hospital